Professor Max Reynolds has over half a century of global experience in scientific research, business and product development.
His commitment and determination to exploring biotechnology and discovering new practical uses for it has led to many advances, including the development of 98alive™, which is produced by 98 Alive Pty Ltd of which Professor Reynolds is also the Managing Director.
Professor Reynolds has previously lectured at leading Australian university, Griffith University in Brisbane, Queensland and has held the position of Director of the Program in Australasia Botanical Medicine for Population Health.
Professor Max Reynolds was one of five international Keynote speakers at the 3rd International Conference on Clinical Microbiology & Microbial Genomics in Valencia Spain on Sept 24-26. His presentation was titled “A New and Effective Treatment for Dengue Fever.” The other Keynote speakers came from USA, UK, New Zealand and Greece.
There were around 80 other speakers from around the world at this conference.